Literature DB >> 8843366

Oxygenation and metabolic status of KHT tumors as measured simultaneously by 19F magnetic resonance imaging and 31P magnetic resonance spectroscopy.

N J Baldwin1, T C Ng.   

Abstract

To evaluate the relationship between the partial pressure of oxygen (pO2) and the energy-related phosphorous metabolites in individual KHT murine sarcomas more clearly, the spatial distributions of pO2 were obtained simultaneously with 31P magnetic resonance spectra, and repeatedly as a function of growth. The pO2 maps, derived from serial images of the spin-lattice relaxation times of sequestered perfluorocarbon emulsions, were heterogeneous spatially, which is characteristic of solid tumors. Collectively, the median pO2 of the seven KHT tumors of mass varying from 0.2 to 1.8 g decreased from 60 to 0 mmHg, but it increased in one of five tumors which were followed in the growth study. The pHMRS and the high-energy ratio of phosphocreatine + nucleoside triphosphates to total observed phosphorous (TP) dropped on average as a function of tumor growth, while the low energy ratio of P(i) to TP increased. Also, for the tumors as a whole, the pH and high-energy ratio increased with increasing median pO2 while the low energy ratio decreased, but the 31P values of some tumors did not follow this general trend. These individual variations suggest the need for simultaneous and repeated measurements of phosphorous metabolites and oxygen tension for complete information regarding the tumor status in experimental studies and therapeutic procedures in humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843366     DOI: 10.1016/0730-725x(96)00049-5

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  9 in total

1.  In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI.

Authors:  Deepak K K Kadayakkara; Jelena M Janjic; Lisa K Pusateri; Won-Bin Young; Eric T Ahrens
Journal:  Magn Reson Med       Date:  2010-09-21       Impact factor: 4.668

Review 2.  New frontiers and developing applications in 19F NMR.

Authors:  Jian-Xin Yu; Rami R Hallac; Srinivas Chiguru; Ralph P Mason
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2012-11-02       Impact factor: 9.795

Review 3.  Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer.

Authors:  Kristine Glunde; Dmitri Artemov; Marie-France Penet; Michael A Jacobs; Zaver M Bhujwalla
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

4.  Tissue oxygen tension measurements in the Shionogi model of prostate cancer using 19F MRS and MRI.

Authors:  J A McNab; A C Yung; P Kozlowski
Journal:  MAGMA       Date:  2004-12-16       Impact factor: 2.310

5.  Exploiting the Fluxionality of Lanthanide Complexes in the Design of Paramagnetic Fluorine Probes.

Authors:  Randall K Wilharm; Mandapati V Ramakrishnam Raju; John C Hoefler; Carlos Platas-Iglesias; Valérie C Pierre
Journal:  Inorg Chem       Date:  2022-02-23       Impact factor: 5.165

6.  In vivo imaging of changes in tumor oxygenation during growth and after treatment.

Authors:  Anna Bratasz; Ramasamy P Pandian; Yuanmu Deng; Sergey Petryakov; John C Grecula; Nilendu Gupta; Periannan Kuppusamy
Journal:  Magn Reson Med       Date:  2007-05       Impact factor: 4.668

Review 7.  Current issues in the utility of 19F nuclear magnetic resonance methodologies for the assessment of tumour hypoxia.

Authors:  Simon P Robinson; John R Griffiths
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

Review 8.  Molecular mechanisms of hypoxia in cancer.

Authors:  Amarnath Challapalli; Laurence Carroll; Eric O Aboagye
Journal:  Clin Transl Imaging       Date:  2017-05-11

9.  In vivo intracellular oxygen dynamics in murine brain glioma and immunotherapeutic response of cytotoxic T cells observed by fluorine-19 magnetic resonance imaging.

Authors:  Jia Zhong; Masashi Sakaki; Hideho Okada; Eric T Ahrens
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.